Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Aprotinin manufacturers

Filters

None products found

aprotinin

Injection 100000 KIU, 200000 KIU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, PICS, MHRA, WHO
Manufacturer #38657

The company is a pharmaceutical manufacturer engaged in the development, production and export of a range of pharmaceutical products across key therapeutic segments including oncology, critical care and lifesaving medicines, operating with certified manufacturing capabilities and global distribution networks to supply these pharmaceutical products to international healthcare markets.

Manufacturer usually replies in 7 days

aprotinin

Solution for injection 10 000 IU / 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Moldova
GMP approvals
WHO
Manufacturer #17541
A transnational pharmaceutical manufacturer producing a wide portfolio of pharmaceutical products and supplements across multiple dosage forms, including injectable and infusion medicines, tablets, capsules and oral powders. It operates several modern production complexes in Eastern Europe, including a large facility with multiple industrial flows built to international standards, and holds national GMP certification for both sterile and non-sterile manufacturing as well as in-house quality control. The company focuses on delivering high-quality, affordable pharmaceutical products in therapeutic areas such as oncology, hormonal therapies, nervous-system disorders, cardiovascular and digestive diseases, pain management and anti-inflammatory care.

Manufacturer usually replies in 2 days

aprotinin

Solution for injection 100 000 IU, 500 000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303
A pharmaceutical manufacturer with over 25 years of experience that develops and produces fixed-dose and single-entity generic and specialty pharmaceutical products. The company offers an extensive range of injectable dosage forms, including parenterals, and also manufactures oral solids. Its facilities operate under recognised international quality certifications such as EU-GMP, ANVISA, PIC/S and TGA approvals, supporting reliable large-scale production of pharmaceutical products for global export while emphasizing efficacy, affordability and consistent quality.

Manufacturer usually replies in 20 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Aprotinin Manufacturers

Aprotinin is a serine protease inhibitor used in high-risk patients undergoing cardiopulmonary bypass for coronary artery bypass graft surgery to lower the risk of perioperative blood loss and the requirement for blood transfusions. Aprotinin (Trasylol, formerly Bayer and now Nordic Group pharmaceuticals) is a tiny protein bovine pancreatic trypsin inhibitor (BPTI), also known as basic trypsin inhibitor of bovine pancreas, which is Trypsin and related proteolytic enzymes are inhibited by an antifibrinolytic compound. Aprotinin was marketed as Trasylol, a medicine that was injected to minimize bleeding during complicated surgeries such as heart and liver operations. Its main action is to slow down fibrinolysis, the process that causes blood clots to dissolve. Its use was intended to reduce the need for blood transfusions during operation, as well as end-organ damage caused by hypotension (low blood pressure) caused by significant blood loss. After investigations revealed that using the medicine raised the risk of complications or death, the drug was temporarily removed worldwide in 2007. This was verified by follow-up studies. Trasylol sales were halted in May 2008, except for very limited research use. The European Medicines Agency's (EMA) scientific committee reversed its previous position on aprotinin in February 2012, recommending that the suspension be lifted. In 2012, Nordic became an aprotinin distributor.

How does Aprotinin work?

Aprotinin, commonly known as BPTI (Trasylol, Bayer) or bovine pancreatic trypsin inhibitor, is a medication used to prevent bleeding during cardiopulmonary bypass (CPB). Aprotinin slows fibrinolysis, the process that causes blood clots to dissolve.

Wholesale Price of Aprotinin

An online search for the wholesale price for sale of Aprotinin for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Aprotinin distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Aprotinin suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Aprotinin. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Aprotinin is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers' Aprotinin suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Aprotinin Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.